Invention Grant
- Patent Title: Cancer antigen-specific T-cell receptor gene, peptide encoded by the gene, and use of them
-
Application No.: US14184979Application Date: 2014-02-20
-
Publication No.: US10669584B2Publication Date: 2020-06-02
- Inventor: Haruo Sugiyama
- Applicant: International Institute of Cancer Immunology, Inc.
- Applicant Address: JP Osaka
- Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee Address: JP Osaka
- Agency: Finnegan, Henderson Farabow, Garrett & Dunner, L.L.P.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@47ef90b6
- Main IPC: C12P19/34
- IPC: C12P19/34 ; C12Q1/6881 ; C07K14/725 ; C12Q1/6886 ; G01N33/574 ; G01N33/569
Abstract:
Disclosed are: a nucleotide sequence and an amino acid sequence for CDR3 region of T-cell receptor (TCR) gene of WT1-specific cytotoxic T-cell (CTL) for WT1 protein; a method for the detection or treatment of cancer using the nucleotide sequence or the amino acid sequence; and a chip, a primer set, a kit, an apparatus and the like for use in the detection of cancer, each of which comprises the nucleotide sequence or the amino acid sequence.
Public/Granted literature
- US20140315735A1 CANCER ANTIGEN-SPECIFIC T-CELL RECEPTOR GENE, PEPTIDE ENCODED BY THE GENE, AND USE OF THEM Public/Granted day:2014-10-23
Information query
